BuzzSparks.org

Chroma Therapeutics


cancer and inflammation treatments

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically...

Homepage:
Total money raised: $77.5M

OX14 4RY 93 Milton Park
Abingdon

Oxon
Oxon
GBR

Phone: 44-(0)1235-829120

Updated on Apr 30, 2013
Chroma Therapeutics at CrunchBase
Past
James Abell Director

June, 2009

Chroma Therapeutics raised $24.5M in unattributed round from Abingworth, Essex Woodlands Health Ventures, Gilde IT Fund, Wellcome Trust, GlaxoSmithKline, and Nomura Securities

April, 2006

Chroma Therapeutics raised $53M in a Series C round from Nomura Phase4 Ventures, Abingworth, Essex Woodlands Health Ventures, Gilde Healthcare Partners, and Wellcome Trust

CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING    chromatherapeutics.com